Xcyte Therapies' Unattributed VC - III Round

Xcyte Therapies raised a round of funding on November 17, 2001.

Xcyte Therapies, development stage biotechnology company, develops therapeutic products that enhance the body's natural immune responses to treat cancer, infectious diseases, and other medical conditi…

Articles about Xcyte Therapies' Unattributed VC - III Round: